Form 8-K - Current report:
SEC Accession No. 0000950170-21-004876
Filing Date
2021-11-23
Accepted
2021-11-23 17:12:33
Documents
12
Period of Report
2021-11-19
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K eras-20211119.htm   iXBRL 8-K 47231
  Complete submission text file 0000950170-21-004876.txt   166799

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eras-20211119_lab.xml EX-101.LAB 13896
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eras-20211119.xsd EX-101.SCH 2469
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eras-20211119_pre.xml EX-101.PRE 10218
5 EXTRACTED XBRL INSTANCE DOCUMENT eras-20211119_htm.xml XML 4881
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

EIN.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40602 | Film No.: 211439635
SIC: 2834 Pharmaceutical Preparations